Efficacy News and Research

RSS

Research project validates viability of pigments that reduce building temperature, absorb environmental pollution

The Environmental Inorganic Chemistry and Ceramic Materials Group of the Universitat Jaume I (UJI) in Castellón, Spain, has developed a research project to assess, transfer and exploit refreshing and photo-catalytic pigments (cool pigments) with a base of Scheelite that are used to decrease the temperature of buildings and also to absorb part of the environmental pollution.

7 Jan 2019

GE Healthcare and VUMC announce partnership to enable safer, more precise cancer immunotherapies

GE Healthcare and Vanderbilt University Medical Center today announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will be developed to help predict both the efficacy of an immunotherapy treatment and its adverse effects for a specific patient before the therapy is administered.

7 Jan 2019

Alzheimer’s Disease: Learning from the Past, Looking to the Future

An interview with Dr. Lloyd Tran, discussing the major barriers to Alzheimer’s research and development over the past 40 years.

From Alzheimer International Society 3 Jan 2019

Researchers evaluate digital medicine tool to treat children with autism and co-occurring ADHD

Researchers at Children's Hospital of Philadelphia evaluated a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder and co-occurring attention/deficit-hyperactivity disorder.

3 Jan 2019

Scavenging molecule offers long-lasting protection against toxic nerve agents in rodents

For the first time, scientists have created a scavenging molecule that provides long-lasting preventative protection against toxic nerve agents in rodents.

3 Jan 2019

Higher levels of nicotine may help quit smoking, research suggests

Allowing smokers to determine their nicotine intake while they are trying to quit is likely to help them kick the habit, according to an early study in 50 people led by Queen Mary University of London.

2 Jan 2019

New editorial proposes changes to improve minority representation in clinical trials

In an editorial published in CNS Spectrums, Jay Avasarala, MD, PhD, takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).

2 Jan 2019

Study uncovers how tumors backfire on neoadjuvant chemotherapy

Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery. This approach, called 'neoadjuvant' therapy, helps to reduce the size of the tumor to facilitate breast-conserving surgery, and can even eradicate the tumor, leaving few or no cancerous cells for the surgeon to remove.

2 Jan 2019

Multicenter study demonstrates effectiveness, safety of topical antibiotics in NICU babies

A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.

28 Dec 2018

CWRU researcher receives nearly $1 million to study drug resistance mechanisms in prostate cancer

Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 over three years to investigate drug resistance mechanisms in prostate cancer.

24 Dec 2018

New treatment for adults with rare, life-threatening blood disease receives FDA approval

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

21 Dec 2018

FDA approves new treatment for rare disease of the bone marrow and blood

The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.

21 Dec 2018

New vaccine shows promise against chikungunya virus

A live vaccine genetically engineered from a common measles vaccine promises to be effective against the chikungunya virus. Such is the central finding of a recently completed Phase II trial now published in the prestigious journal "The Lancet".

21 Dec 2018

New bacteria-based drug delivery system could radically expand cancer treatment options

An interdisciplinary team of three Virginia Tech faculty members affiliated with the Macromolecules Innovation Institute has created a drug delivery system that could radically expand cancer treatment options.

21 Dec 2018

Experts in Parkinson's research propose roadmap for drug trials targeting alpha-synuclein

A recently discovered protein, alpha-synuclein, has become one of the most attractive targets for developing new drugs with the potential to slow down or arrest the progression of Parkinson's disease

20 Dec 2018

Using mobile phone-based intervention to encourage Chinese smokers to quit the habit

Among smokers receiving a 12-week-long mobile phone-based intervention encouraging them to quit, up to 6.5% of participants stopped smoking by the end of the study, according to a research article published this week in the open-access journal PLOS Medicine by Jinsong Tang of the Second Xiangya Hospital of Central South University in China, and colleagues.

20 Dec 2018

Efficacy News and Research

Research project validates viability of pigments that reduce building temperature, absorb environmental pollution

GE Healthcare and VUMC announce partnership to enable safer, more precise cancer immunotherapies

Alzheimer’s Disease: Learning from the Past, Looking to the Future

Researchers evaluate digital medicine tool to treat children with autism and co-occurring ADHD

Scavenging molecule offers long-lasting protection against toxic nerve agents in rodents

Higher levels of nicotine may help quit smoking, research suggests

New editorial proposes changes to improve minority representation in clinical trials

Study uncovers how tumors backfire on neoadjuvant chemotherapy

Multicenter study demonstrates effectiveness, safety of topical antibiotics in NICU babies

CWRU researcher receives nearly $1 million to study drug resistance mechanisms in prostate cancer

New treatment for adults with rare, life-threatening blood disease receives FDA approval

FDA approves new treatment for rare disease of the bone marrow and blood

New vaccine shows promise against chikungunya virus

New bacteria-based drug delivery system could radically expand cancer treatment options

Experts in Parkinson's research propose roadmap for drug trials targeting alpha-synuclein

Using mobile phone-based intervention to encourage Chinese smokers to quit the habit

WU biomedical engineer makes a significant step toward precision medicine

Researchers synthesize new compound that inhibits replication of hepatitis C virus

Horizon Discovery partners with C4XD to validate novel synthetic lethal oncology targets

Developing the Next Generation of Water-soluble DREADDs

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News